Dexcom announced its first over-the-counter continuous glucose monitor (CGM) device at CES 2025, while Abbott showcased its device launched at CES 2022 and available to consumers since last year. Many people with diabetes and insulin-related health issues struggle to find accessible and affordable care, making these products a potential game changer in the healthcare sphere.
Also: CES 2025: The most impressive products so far
People without diabetes also use glucose monitoring to help make adjustments to their eating habits and improve overall health. So, the Lingo by Abbott and the Stelo by Dexcom could benefit a wide variety of users.
<!–>
Stelo by Dexcom tracks glucose levels 24/7
This CGM is designed for general wellness tracking but Dexcom emphasizes it was also designed to empower those with Type 2 diabetes who are not on insulin and prediabetics who are 18 years or older. The sensor, a “small, flexible wire,” is inserted under your skin by an applicator and tracks glucose levels 24/7. Each sensor lasts up to 30 days and is connected to an app on your iPhone or Android that delivers your readings.
Also: The best CES 2025 products you can buy right now
Previously, the company sold similar devices, but they were much more expensive and sometimes involved insurance for them to be accessible.
–>